about
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategiesStructural basis for bisphosphonate-mediated inhibition of isoprenoid biosynthesisGeranylgeranyl diphosphate synthase: an emerging therapeutic targetOsteolytica: An automated image analysis software package that rapidly measures cancer-induced osteolytic lesions in in vivo models with greater reproducibility compared to other commonly used methodsReactive oxygen species and autophagy associated apoptosis and limitation of clonogenic survival induced by zoledronic acid in salivary adenoid cystic carcinoma cell line SACC-83Controlled delivery of zoledronate improved bone formation locally in vivoTheoretical and Instrumental Studies of the Competitive Interaction Between Aromatic α-Aminobisphosphonates with DNA Using Binding Probes.New symmetrically esterified m-bromobenzyl non-aminobisphosphonates inhibited breast cancer growth and metastases.Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk.Targeted treatments of bone metastases in patients with lung cancerBisphosphonates regulate cell proliferation, apoptosis and pro-osteoclastic expression in MG-63 human osteosarcoma cells.Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells.A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort studyZoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by increasing p53 expression levels.Use of bisphosphonates and reduced risk of colorectal cancer.Bisphosphonates pathway.Three cases of bone metastases in patients with gastrointestinal stromal tumors.Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer.Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis.The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future.Bisphosphonate therapy in the oncology setting.Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells.State-of-the-art approaches to detecting early bone metastasis in prostate cancer.Potential of human gammadelta T lymphocytes for immunotherapy of cancer.Bisphosphonates and bone metastases: current status and future directions.A prospective study of bisphosphonate use and risk of colorectal cancerBiphosphonates in advanced prostate and renal cell cancer--current status and potential applications.Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cellsPathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases.Pamidronate Down-regulates Tumor Necrosis Factor-alpha Induced Matrix Metalloproteinases Expression in Human Intervertebral Disc Cells.Enhancement of taxol, doxorubicin and zoledronate anti-proliferation action on triple-negative breast cancer cells by a PTHrP blocking monoclonal antibodySignificant pain relief with loading dose zoledronic acid in bone metastases is only seen in patients with elevated initial serum C telopeptide (CTX).VALIDATION OF THERAPEUTIC RESPONSE ASSESSMENT BY BONE SCINTIGRAPHY IN PATIENTS WITH BONE-ONLY METASTATIC BREAST CANCERS DURING ZOLEDRONIC ACID TREATMENT: COMPARISON WITH COMPUTED TOMOGRAPHY ASSESSMENT.An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.Zoledronic acid: an unending tale for an antiresorptive agent.KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.Immunotherapy targeting colon cancer stem cells.Pharmacokinetic evaluation of zoledronic acid.Animal models for breast cancer metastasis to bone: opportunities and limitations.A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [(18)F]FMAU-Positron Emission Tomography Imaging of Bone Metastases in Prostate Cancer.
P2860
Q24568071-D6FA634D-F46F-4E37-BA7B-C0916D966EBBQ27642782-6066F798-902F-43C4-888F-D6106BE14825Q28252056-26B6C5C7-8360-46AE-944C-B8C7449BF91EQ28364664-C711537E-2AE8-4F84-AA8B-600172B3D773Q28540022-A4BE909F-364E-4963-8FDD-6741EEA0EDCEQ28540762-33061008-8F95-4AB7-82BD-83920A386B37Q32182879-30AA8CF5-9D6C-4F1D-B145-57E320313880Q33415020-8437D8F7-250D-4822-9250-A5B2DDB3B01CQ33708123-68D7ACDC-64A1-4800-9D02-E32C8F1CF33AQ33759713-F48D4F39-9D43-47D6-9791-ABF6075C3F0AQ34356336-90F84BCA-AC14-45BD-A68F-9B310E8F2417Q34395222-B1412D6C-98DB-494C-AF3F-FFAE20DC6F6FQ34541581-2A79D023-B6AE-4117-8F1A-662D4784BA8AQ34653709-44EC460C-0B22-472F-83AE-8BAAD37311E7Q34877539-F6F0EE32-1E2C-426C-A1C0-8254B5064D93Q34905878-6C74B5D5-26AD-4D51-B8DB-736D3F564033Q35093218-D341FE63-A82E-46D6-A71E-57BBB26D3DB8Q35227499-F0CDF1CC-BB6B-452B-BC06-FBCEB0A71507Q35259094-DE585CE7-2199-4A72-8B4E-28438B88F5F8Q35584866-FA0312BF-CE94-49DE-BA24-F188AC41AC19Q35602668-AA06B36A-CE07-4947-A2AD-9D53859D30F2Q35754021-6E4B1D63-2871-4A96-AEC3-D4C50E88FD02Q35854984-6F834E4C-D3F0-4962-BA39-0D994036FBA4Q35896206-58C55762-E622-499E-B97B-76225DDC95B0Q36118409-4E1907E3-0E59-49F6-B244-1F33EDEE4B8BQ36212417-A1239DDD-2D32-480D-99CE-3B98ECFD8DF0Q36403183-98BF8238-6856-42A2-9EFA-F2C24D419599Q36491662-CED8EDB8-F74F-45FF-9251-E03A922EB34FQ37170651-C04A84A2-E982-4CB0-B981-A67AABF8E9DFQ37247142-C485726B-8E55-46F6-8FCC-1F9D8C998F83Q37278425-791BC9F0-599E-49DD-B900-DD3A3E4920A4Q37300864-E979F809-8575-411A-95D2-7D416095CB4AQ37460998-72C86BED-4949-4979-B7F1-EFFE09D34311Q37486791-C33A92D8-EB70-4313-BEAB-3F2B6E602ECDQ37650334-BC830A93-987E-4EC7-ADDD-A189A6D406E2Q37694808-F3D93D04-6D0B-4D0F-94B8-0A8BF5BD2B54Q37822747-A74B620E-585E-461F-86A4-8254B507E0E5Q37874629-E8CB7C88-5CDA-4ADE-9776-C46AB74C8626Q38573510-238D6915-1DEF-4680-A8E5-9E558E142815Q38746311-53649183-DE10-4BB3-BC46-4C3519C4A77C
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antitumor effects of bisphosphonates.
@ast
Antitumor effects of bisphosphonates.
@en
type
label
Antitumor effects of bisphosphonates.
@ast
Antitumor effects of bisphosphonates.
@en
prefLabel
Antitumor effects of bisphosphonates.
@ast
Antitumor effects of bisphosphonates.
@en
P356
P1433
P1476
Antitumor effects of bisphosphonates.
@en
P2093
Jonathan R Green
P304
P356
10.1002/CNCR.11128
P407
P433
P577
2003-02-01T00:00:00Z